iX Biopharma Ltd announced the allotment and issuance of 47,353 new ordinary shares on Nov, 19 2025, following the exercise of warrants at 0.06 Singapore dollars per share.
As a result, the company’s total issued share capital rose to 955,980,766 shares from 955,933,413 shares.
The newly issued shares will rank pari passu with existing shares and are expected to commence trading on the Singapore Exchange on Nov, 21 2025.
After this transaction, 56,488,158 warrants remain outstanding, each exercisable at 0.06 Singapore dollars and expiring on Jul, 18 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.